SCHEMBL23315

SCHEMBL23315

CN[C@@H](C)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21800791 1.00 TP53 (0.44)
SCHEMBL164982 1.00
SCHEMBL718640 1.00 TP53 (0.44)
SCHEMBL21399 1.00
Potassium SCHEMBL373504 0.97
SCHEMBL1960968 0.97
Hydrochloric Acid SCHEMBL2971887 0.97
SCHEMBL1960962 0.97
SCHEMBL4412794 0.97
Hydrochloric Acid SCHEMBL1027048 0.97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 13115 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747627-A1 METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS Matterworks Inc (US) 2026-05-27 EP claimed
CN-116457073-B Solvent solution and method KC8捕集技术有限公司 2026-05-15 CN claimed
CN-122028793-A Fungicidal compositions 先正达农作物保护股份公司 2026-05-12 CN claimed
US-20260116921-A1 PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES PROTAGONIST THERAPEUTICS INC (US) 2026-04-30 US claimed
EP-4727655-A1 DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF Mariana Oncology Inc. (US) 2026-04-22 EP claimed
EP-4727654-A1 DLL3 TARGETING PEPTIDES AND CONSTRUCTS THEREOF Mariana Oncology Inc. (US) 2026-04-22 EP claimed
US-12606569-B2 Alkaloid-containing compositions and uses thereof BIOTELLIGA HOLDINGS LIMITED (NZ) 2026-04-21 US claimed
EP-4719381-A1 LIGAND-POLAR DRUG CONJUGATES Tripartite Therapeutics Inc. (TW) 2026-04-08 EP claimed
EP-4720086-A1 PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR Zealand Pharma A/S (DK) 2026-04-08 EP claimed
EP-4720087-A1 PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR Zealand Pharma A/S (DK) 2026-04-08 EP claimed
US-4849541-A Process for the preparation of N-L-aminodicarboxylic acid esters and new compositions used in the preparation thereof GENERAL FOODS CORPORATION (US) 1989-07-18 US claimed
EP-0118280-B1 ENZYME INHIBITION Aktiebolaget Hässle (SE) 1989-07-12 EP claimed
US-4772686-A ANTICOAGULANTS AKTIEBOLAGET HASSLE (SE) 1988-09-20 US claimed
US-4672106-A ANTITUMOR AGENTS Hamaoka, Toshiyuki (JP) 1987-06-09 US claimed
US-4638047-A Enzyme inhibition AKTIEBOLAGET HASSLE (SE) 1987-01-20 US claimed
EP-0203031-A2 Biologically active lysine containing octapeptides The Administrators of The Tulane University Educational Fund (US) 1986-11-26 EP claimed
EP-0173960-A2 Muramylpeptide active ester derivatives Hamaoka, Toshiyuki (JP) 1986-03-12 EP claimed
EP-0124388-A1 Strain of Trichoderma harzianum, process for its isolation, process for its culture, peptides or compounds produced by this strain and application of this strain and these peptides or the product produced by the culture process as a means for biological control in the form of a phytosanitary product LES PRODUITS ORGANIQUES DU SANTERRE ORSAN (FR) 1984-11-07 EP claimed
WO-1984003507-A1 ENZYME INHIBITION FERRING AB (SE) 1984-09-13 WO claimed
EP-0118280-A1 Enzyme inhibition Aktiebolaget Hässle (SE) 1984-09-12 EP claimed